Evidence map›Paper›PMID 32033227›Full record

Trial reportInternational journal of environmental research and public health2020

Improving Screening Uptake among Breast Cancer Survivors and Their First-Degree Relatives at Elevated Risk to Breast Cancer: Results and Implications of a Randomized Study in the State of Georgia.

Joseph Lipscomb, Cam Escoffery, Theresa W Gillespie, S Jane Henley, Robert A Smith, Toni Chociemski, Lyn Almon, Renjian Jiang, Xi Sheng, Michael Goodman and 1 more

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in International journal of environmental research and public health, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 13 citations in OpenAlex.

  1. Testing a Population-Based Outreach Intervention for Ovarian Cancer Survivors to Encourage their Close Relatives to Consider Genetic Counseling.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2024
    Trial
  2. Trial
  3. Breast cancer prevention in patients with gBRCA-mutated ovarian cancer.Journal of cancer research and clinical oncology · 2026
    Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Joseph LipscombRollins School of Public Health, Emory University; Atlanta, GA 30322, USA.
Cam EscofferyRollins School of Public Health, Emory University; Atlanta, GA 30322, USA.
Theresa W GillespieWinship Cancer Institute of Emory University; Atlanta, GA 30322, USA.
S Jane HenleyDivision of Cancer Prevention and Control, U.S. Centers for Disease Control and Prevention; Atlanta, GA 30341, USA.ORCID 0000-0002-2420-306X
Robert A SmithRollins School of Public Health, Emory University; Atlanta, GA 30322, USA.
Toni ChociemskiRollins School of Public Health, Emory University; Atlanta, GA 30322, USA.
Lyn AlmonRollins School of Public Health, Emory University; Atlanta, GA 30322, USA.
Renjian JiangRollins School of Public Health, Emory University; Atlanta, GA 30322, USA.
Xi ShengRollins School of Public Health, Emory University; Atlanta, GA 30322, USA.
Michael GoodmanRollins School of Public Health, Emory University; Atlanta, GA 30322, USA.
Kevin C WardRollins School of Public Health, Emory University; Atlanta, GA 30322, USA.
Emory University · USAmerican Cancer Society · USCenters for Disease Control and Prevention · US

Funding

GEORGIA COMPREHENSIVE CANCER CONTROL PROGRAMU58DP003875 · DP · GEORGIA DIVISION OF PUBLIC HEALTH · PI O'CONNOR, JEAN CATHERINE · 2012 to 2014
$15.9M
Health Promotion and Disease Prevention Research CenterU48DP006377 · DP · EMORY UNIVERSITY · PI KEGLER, MICHELLE C · 2018 to 2023
$13.5M
EMORY PREVENTION RESEARCH CENTERU48DP001909 · DP · EMORY UNIVERSITY · PI KEGLER, MICHELLE C · 2009 to 2013
$10.7M
CDC HHS 5NU58DP003875-04-00NCCDPHP CDC HHS U48 DP001909NCCDPHP CDC HHS U48 DP006377NCCDPHP CDC HHS U58 DP003875NCI NIH HHS HHSN26100006
6 · The paper itself

Abstract

Women diagnosed with breast cancer at a relatively early age (≤45 years) or with bilateral disease at any age are at elevated risk for additional breast cancer, as are their female first-degree relatives (FDRs). We report on a randomized trial to increase adherence to mammography screening guidelines among survivors and FDRs. From the Georgia Cancer Registry, breast cancer survivors diagnosed during 2000-2009 at six Georgia cancer centers underwent phone interviews about their breast cancer screening behaviors and their FDRs. Nonadherent survivors and FDRs meeting all inclusion criteria were randomized to high-intensity (evidence-based brochure, phone counseling, mailed reminders, and communications with primary care providers) or low-intensity interventions (brochure only). Three and 12-month follow-up questionnaires were completed. Data analyses used standard statistical approaches. Among 1055 survivors and 287 FDRs who were located, contacted, and agreed to participate, 59.5% and 62.7%, respectively, reported breast cancer screening in the past 12 months and were thus ineligible. For survivors enrolled at baseline (

Indexed as

Breast NeoplasmsCancer SurvivorsEarly Detection of CancerPatient ComplianceAdultCounselingFemaleGeorgiaHumansMass ScreeningMiddle AgedRegistriesSurveys and QuestionnairesTelephonebreast cancer survivorscancer registriescommunity-based researchdisease screeningfirst-degree relativesguideline adherencepopulation-based genetic risk screening

Identifiers

PMID32033227
PMCPMC7037204
OpenAlexW3004469874

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.